The Improving Continuous Cardiac Care (IC3) Program and Outpatient Quality Improvement - 19/08/11
Doi : 10.1016/j.amjmed.2009.09.019
Paul S. Chan, MD, MSc a, ⁎ 
, William J. Oetgen, MD, MBA b, John A. Spertus, MD, MPH a
, William J. Oetgen, MD, MBA b, John A. Spertus, MD, MPH a a Mid America Heart Institute and the University of Missouri, Kansas City
b Georgetown University School of Medicine, Washington, DC
Requests for reprints should be addressed to Paul S. Chan, MD, MSc, Mid America Heart Institute, 4401 Wornall Road, 5th Floor, Kansas City, MO 64111
Le texte complet de cet article est disponible en PDF.
Plan
| Kim A. Eagle, MD, Section Editor |
|
| Funding: Bristol-Myers Squibb/Sanofi Pharmaceuticals and the American College of Cardiology provide operational funding for the Improving Continuous Cardiac Care program. |
|
| Conflict of Interest: None of the authors have any financial conflicts of interest. |
|
| Authorship: Drs. Chan and Spertus had full access to all of the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis. All authors participated in: interpretation of the data, drafting of the manuscript, and critical revision of this manuscript for important intellectual content. |
© 2010
Elsevier Inc. Tous droits réservés.
Vol 123 - N° 3
P. 217-219 - mars 2010 Retour au numéro
Article précédent
- Diabetic Retinopathy: An Update on Treatment
- Ryan J. Fante, Vikram D. Durairaj, Scott C.N. Oliver
- Exotic Origin, Familiar Culprit
- Tinsay A. Woreta, Leonard S. Feldman, Rosalyn W. Stewart
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?